Chris Stevens
Keine laufenden Positionen mehr
Profil
Chris Stevens worked as a Medical Director at CB Biomedical, Inc. and Altus Pharmaceuticals, Inc. He was also the Chief Medical Officer at Arsanis, Inc. from 2016 to 2019 and at Astria Therapeutics, Inc. from 2021 to 2022.
In addition, he served as the Senior Vice President-Clinical Development at Alnara Pharmaceuticals, Inc. from 2009 to 2011.
Prior to his industry experience, he was an Assistant Professor at Harvard Medical School.
Dr. Stevens holds a doctorate from the University of Miami and an undergraduate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Chris Stevens
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2022 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 15.01.2019 |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2011 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
CB Biomedical, Inc.
 CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Chris Stevens
| The University of North Carolina at Charlotte | Undergraduate Degree |
| University of Miami | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
CB Biomedical, Inc.
CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Commercial Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
